Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Polymorphisms in oxidative stress genes, physical activity, and breast cancer risk.

McCullough LE, Santella RM, Cleveland RJ, Bradshaw PT, Millikan RC, North KE, Olshan AF, Eng SM, Ambrosone CB, Ahn J, Steck SE, Teitelbaum SL, Neugut AI, Gammon MD.

Cancer Causes Control. 2012 Dec;23(12):1949-58. doi: 10.1007/s10552-012-0072-1. Epub 2012 Sep 29.

2.

Polymorphisms in DNA repair genes, recreational physical activity and breast cancer risk.

McCullough LE, Santella RM, Cleveland RJ, Millikan RC, Olshan AF, North KE, Bradshaw PT, Eng SM, Terry MB, Shen J, Crew KD, Rossner P Jr, Teitelbaum SL, Neugut AI, Gammon MD.

Int J Cancer. 2014 Feb 1;134(3):654-63. doi: 10.1002/ijc.28383. Epub 2013 Aug 29.

3.

Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.

Quick SK, Shields PG, Nie J, Platek ME, McCann SE, Hutson AD, Trevisan M, Vito D, Modali R, Lehman TA, Seddon M, Edge SB, Marian C, Muti P, Freudenheim JL.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1082-7. doi: 10.1158/1055-9965.EPI-07-2755.

4.

Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk.

Li Y, Ambrosone CB, McCullough MJ, Ahn J, Stevens VL, Thun MJ, Hong CC.

Carcinogenesis. 2009 May;30(5):777-84. doi: 10.1093/carcin/bgp053. Epub 2009 Mar 2.

PMID:
19255063
5.

Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer.

Hong CC, Ambrosone CB, Ahn J, Choi JY, McCullough ML, Stevens VL, Rodriguez C, Thun MJ, Calle EE.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1784-94. Epub 2007 Aug 28.

6.

Polymorphisms in oxidative stress-related genes and postmenopausal breast cancer risk.

Seibold P, Hein R, Schmezer P, Hall P, Liu J, Dahmen N, Flesch-Janys D, Popanda O, Chang-Claude J.

Int J Cancer. 2011 Sep 15;129(6):1467-76. doi: 10.1002/ijc.25761. Epub 2011 Jan 6.

7.

A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.

Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.

Breast Cancer Res Treat. 2007 Jan;101(1):73-81. Epub 2006 Jun 29. Erratum in: Breast Cancer Res Treat. 2007 Apr;102(2):249.

PMID:
16807674
8.

Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.

Udler M, Maia AT, Cebrian A, Brown C, Greenberg D, Shah M, Caldas C, Dunning A, Easton D, Ponder B, Pharoah P.

J Clin Oncol. 2007 Jul 20;25(21):3015-23.

PMID:
17634480
9.

Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.

Wang Q, Li H, Tao P, Wang YP, Yuan P, Yang CX, Li JY, Yang F, Lee H, Huang Y.

DNA Cell Biol. 2011 Aug;30(8):585-95. doi: 10.1089/dna.2010.1195. Epub 2011 Mar 27.

PMID:
21438753
10.

A genetic variant in the promoter of APE1 gene (-656 T>G) is associated with breast cancer risk and progression in a Chinese population.

Kang H, Dai Z, Ma X, Ma L, Jin Y, Liu X, Wang X.

Gene. 2013 Nov 15;531(1):97-100. doi: 10.1016/j.gene.2013.08.052. Epub 2013 Aug 28.

PMID:
23994194
11.

Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population.

Sinotte M, Rousseau F, Ayotte P, Dewailly E, Diorio C, Giguère Y, Bérubé S, Brisson J.

Endocr Relat Cancer. 2008 Dec;15(4):975-83. doi: 10.1677/ERC-08-0056. Epub 2008 Aug 21.

12.

Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.

Kataoka N, Cai Q, Wen W, Shu XO, Jin F, Gao YT, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1148-52.

13.

Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk.

Rylander-Rudqvist T, Wedren S, Granath F, Humphreys K, Ahlberg S, Weiderpass E, Oscarson M, Ingelman-Sundberg M, Persson I.

Carcinogenesis. 2003 Sep;24(9):1533-9. Epub 2003 Jul 4.

PMID:
12844487
14.

A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer.

Shields PG, Ambrosone CB, Graham S, Bowman ED, Harrington AM, Gillenwater KA, Marshall JR, Vena JE, Laughlin R, Nemoto T, Freudenheim JL.

Mol Carcinog. 1996 Nov;17(3):144-50.

PMID:
8944074
15.

MnSOD and CAT polymorphisms modulate the effect of the Mediterranean diet on breast cancer risk among Greek-Cypriot women.

Kakkoura MG, Demetriou CA, Loizidou MA, Loucaides G, Neophytou I, Malas S, Kyriacou K, Hadjisavvas A.

Eur J Nutr. 2016 Jun;55(4):1535-44. doi: 10.1007/s00394-015-0971-5. Epub 2015 Jul 1.

PMID:
26130326
16.
17.

The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.

Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Venter DJ, Southey MC, Chenevix-Trench G.

Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):439-43.

18.

Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer.

Zhang Y, Newcomb PA, Egan KM, Titus-Ernstoff L, Chanock S, Welch R, Brinton LA, Lissowska J, Bardin-Mikolajczak A, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Garcia-Closas M.

Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):353-8.

19.

Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.

Xie D, Shu XO, Deng Z, Wen WQ, Creek KE, Dai Q, Gao YT, Jin F, Zheng W.

J Natl Cancer Inst. 2000 Mar 1;92(5):412-7.

PMID:
10699071
20.

Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.

Wedrén S, Magnusson C, Humphreys K, Melhus H, Kindmark A, Stiger F, Branting M, Persson I, Baron J, Weiderpass E.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1775-83.

Supplemental Content

Support Center